Gene: CYP27A1
Official Full Name: cytochrome P450 family 27 subfamily A member 1provided by HGNC
Gene Summary: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03128 | CYP27A1 Knockout cell line (HEK293) | Human | CYP27A1 | 1:3~1:6 | Negative | Online Inquiry |
CYP27A1 Gene Knockout Cell Lines are genetically engineered cell lines characterized by the targeted disruption of the CYP27A1 gene, which encodes for the enzyme cholesterol 27-hydroxylase. This enzyme plays a crucial role in the metabolism of cholesterol, facilitating the conversion of cholesterol to bile acids and influencing steroidogenesis and cellular signaling pathways. By creating knockout models, researchers can study the resultant phenotypic changes, unraveling the gene's functional contributions to lipid metabolism, inflammatory responses, and various chronic diseases.
The CYP27A1 gene knockout cell lines work by leveraging CRISPR/Cas9 technology or other gene editing tools that ensure accurate and efficient gene disruption. This allows for the investigation of the cellular and molecular implications of diminished CYP27A1 activity, including alterations in lipid profiles and subsequent impacts on cellular functions. The ability to reproduce specific conditions present in disease states provides invaluable insights for developing therapeutic strategies and understanding disease mechanisms.
The scientific importance and applications of CYP27A1 knockout models cannot be overstated. These cell lines are essential for research focusing on metabolic disorders, atherosclerosis, and liver conditions, offering a unique platform for screening potential drug candidates and elucidating new biomarkers. In clinical settings, understanding CYP27A1’s role could lead to innovative treatments for conditions such as hyperlipidemia or cholesterol metabolism disorders.
Compared to traditional wild-type cell lines or less precise gene-editing methods, CYP27A1 knockout cell lines offer researchers a more reliable and precise model that enables better reproducibility and clarity in experimental outcomes. Their specificity in targeting lipid metabolism pathways also means that they can provide unique insights that alternatives may overlook.
For researchers and clinicians delving into metabolic pathways or exploring therapeutic avenues for lipid disorders, CYP27A1 gene knockout cell lines represent a powerful tool. Their capacity to generate relevant and translational data underscores the potential for advancing scientific understanding and clinical practice alike. Our company prides itself on delivering high-quality genetic products backed by advanced technology and a deep understanding of molecular biology, ensuring that you have the best resources available to fuel your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.